Prostate Cancer Vaccine
Vaccine therapy for prostate cancer reviewed
Published in Cancer Vaccine Week, November 28th, 2005
According to a study from Germany, "Vaccine therapy of prostate cancer has been increasingly studied in trials over the past few years. The different vaccine techniques are quite variable and are predominantly used in patients with advanced hormone-refractory prostate cancer. In this review, vaccine techniques using tumor cells, dendritic cells, or poxvirus are analyzed. For theses approaches phase-III trials are being planned, have been initiated or are already completed."
"Many trials demonstrate the efficacy with regard to endpoints such as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Vaccine Week
Source: Cancer Vaccine Week (2005-11-28)
More Articles from Cancer Vaccine Week
- Breast Cancer Vaccine
Aromatase inhibitors increase tumor sensitivity to cytotoxicity - Cancer Vaccine
Fusion protein vaccine generates potent antitumor effects - Cancer Vaccine
RAFT scaffolds look promising for developing anticancer vaccines - Human Papillomavirus Vaccine
DNA vaccines based on chimeric potyvirus-like particles carrying HPV16 E7 peptide developed - Leukemia Vaccine
Responses to CD40 ligand/IL-2 autologous cell vaccine transient - Apoptosis
3-Hydrogenkwadaphnin induced apoptosis in human leukemia cell lines - More from this issue of Cancer Vaccine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
